The Stoffel lab (ETH Zurich) in collaboration with the Tuschl lab (Rockefeller University) discovered that the RNA binding protein A1CF regulates the activities of important metabolic enzymes through controlling which of the alternatively spliced isoforms is expressed. The publication entitled "The RNA-Binding Protein A1CF Regulates Hepatic Fructose and Glycerol Metabolism via Alternative RNA Splicing" was published in Cell Reports.
- A1CF regulates alternative splicing of liver-enriched transcripts
- A1CF is required for the high-activity ketohexokinase-C (KHK-C) isoform
- Antagonistic actions of hnRNPH1/2 and A1CF mediate KHK-A/KHK-C switch
- A1CF regulates fructolysis and glucose production in the liver
The regulation of hepatic gene expression has been extensively studied at the transcriptional level; however, the control of metabolism through posttranscriptional gene regulation by RNA-binding proteins in physiological and disease states is less understood. Here, we report a major role for the hormone-sensitive RNA-binding protein (RBP) APOBEC1 complementation factor (A1CF) in the generation of hepatocyte-specific and alternatively spliced transcripts. Among these transcripts are isoforms for the dominant and high-affinity fructose-metabolizing ketohexokinase C and glycerol kinase, two key metabolic enzymes that are linked to hepatic gluconeogenesis and found to be markedly reduced upon hepatic ablation of A1cf. Consequently, mice lacking A1CF exhibit improved glucose tolerance and are protected from fructose-induced hyperglycemia, hepatic steatosis, and development of obesity. Our results identify a previously unreported function of A1CF as a regulator of alternative splicing of a subset of genes influencing hepatic glucose production through fructose and glycerol metabolism.
Graphical abstract, highlights and summary from Nikolau K.C. et al. (2019) Cell Reports, 29(2), 283-300.e8 published under the CC BY 4.0 license.